Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

Webinar next week: Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi


By Jesse Schwartz
Published: August 15th, 2018

Over the past decade, multiple patents on therapeutic antibodies have been invalidated in the courts, often for lack of written description — and it won’t be getting any easier after the Amgen v. Sanofi Fed Circuit decision. The case indicated that even for a new class of antibodies, the written description requirement can be met only through the disclosure of a “sufficient” number of representative antibodies — including highly specific amino acid sequences. Adding to the challenge is the retroactive application of the ruling, leaving billions in antibody patents at risk.

Research universities invest millions of dollars in discovering and developing antibodies, and they — and their potential licensees — are faced with uncertainty and heightened risk in the wake of these developments.

That’s why Technology Transfer Tactics’ Distance Learning Division has tapped biotech patent expert Kevin E. Noonan, PhD, to lead this critically important webinar: Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi, scheduled for next Thursday, August 23rd.

For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi


By Jesse Schwartz
Published: August 8th, 2018

Over the past decade, multiple patents on therapeutic antibodies have been invalidated in the courts, often for lack of written description — and it won’t be getting any easier after the Amgen v. Sanofi Fed Circuit decision. The case indicated that even for a new class of antibodies, the written description requirement can be met only through the disclosure of a “sufficient” number of representative antibodies — including highly specific amino acid sequences. Adding to the challenge is the retroactive application of the ruling, leaving billions in antibody patents at risk.

Research universities invest millions of dollars in discovering and developing antibodies, and they — and their potential licensees — are faced with uncertainty and heightened risk in the wake of these developments. That’s why Technology Transfer Tactics’ Distance Learning Division has tapped biotech patent expert Kevin E. Noonan, PhD, to lead this critically important webinar: Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi.

For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

International Collaborations and IP Protection


By Jesse Schwartz
Published: August 8th, 2018

To help universities tap into the growing international opportunities for research partnerships — while also ensuring key issues surrounding IP and other contract terms are appropriately addressed — Technology Transfer Tactics’ Distance Learning Division has created International Collaborations and IP Protection, an exclusive collection containing over three hours of expert advice, immediately implementable takeaways, and cost-saving solutions on this critical topic.

Here’s what’s included in this high-value collection.

  • Session One: Best Practices for Safeguarding University IP When Structuring Deals in China
  • Session Two: Building International Sponsored Research Collaborations: Navigating Culture, Contracting, Compliance, and IP Protection
  • Session Three: Best Practices for Cost-Effective Filing of PCT and EPO Patent Applications

For complete program and faculty details and to order, CLICK HERE >>

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Next Week — Open Source Licensing: Risks and Opportunities for University Innovations


By Jesse Schwartz
Published: August 1st, 2018

As TTOs see larger portions of their portfolios occupied by mobile apps, software, and other innovations that build on existing technologies, it’s become critical to gain a solid grasp of the often misunderstood world of open source licensing. It’s a world that is often accompanied by a myriad of risks as well as opportunities.

On the risk side, about half of the code used in all software, including IoT devices, is open source, with dozens of different licensing terms and obligations. And penalties for failure to comply can be severe, including a complete restriction on selling a product incorporating the open source component.

Then there’s the opportunity side — where a growing number of companies are building big valuations using open source business models. There’s a lot to learn, and a lot at stake — that’s why Tech Transfer Central’s Distance Learning Division has scheduled the detailed webinar Open Source Licensing: Risks and Opportunities for University Innovations, coming August 7th.

For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi


By Jesse Schwartz
Published: July 25th, 2018

Over the past decade, multiple patents on therapeutic antibodies have been invalidated in the courts, often for lack of written description — and it won’t be getting any easier after the Amgen v. Sanofi Fed Circuit decision. The case indicated that even for a new class of antibodies, the written description requirement can be met only through the disclosure of a “sufficient” number of representative antibodies — including highly specific amino acid sequences. Disclosure of target antigens without the antibody disclosure will no longer cut it.

And because what constitutes a “sufficient” number is unclear, universities that don’t have the resources to characterize a large number of antibodies before applying for a patent face a significant challenge. Adding to the challenge is the retroactive application of the ruling, leaving billions in antibody patents at risk.

Research universities invest millions of dollars in discovering and developing antibodies, and they — and their potential licensees — are faced with uncertainty and heightened risk in the wake of these developments. That’s why Technology Transfer Tactics’ Distance Learning Division has tapped biotech patent expert Kevin E. Noonan, PhD, to lead this critically important webinar: Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi, scheduled for August 23rd.

For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Protecting and Licensing University Patents in a Post-Oil States and SAS World


By Jesse Schwartz
Published: July 18th, 2018

With its decision in Oil States, the Supreme Court affirmed the Constitutionality of PTAB’s inter partes reviews, but in a simultaneous decision in SAS Institute, it also changed the rulebook for IPR decision-making — changes that have profound ramifications for the entire U.S. patent system – and universities in particular. At the same time, the U.S. Patent Office is changing the standard for how PTAB evaluates claims, moving to the “usual and customary meaning” standard in line with federal courts.

There’s a lot to unpack and digest from these rulings and changes, and they bring both good news and bad — along with plenty of uncertainty — for university TTOs. What do these decisions really mean? How should TTOs adjust their filing strategies to protect their patents? How will the changes affect licensing activity? Will PTAB challenges be more or less likely?

To answer those questions and more, Technology Transfer Tactics’ Distance Learning Division has secured a team of patent attorneys from the law firm Harness, Dickey & Pierce, PLC, who deal with post-grant proceedings on a regular basis, and technology transfer leaders from NUtech Ventures, who will provide the insight and guidance you need to react effectively to the changes. Join us July 25th for this critical webinar: Protecting and Licensing University Patents in a Post-Oil States and SAS World. For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Next week: Webinar on compliance with 2018 Bayh-Dole revisions


By Jesse Schwartz
Published: July 11th, 2018

Important revisions to the Bayh-Dole Act have now taken effect, and it’s critical for universities to ensure their compliance procedures are addressing the new rules. From changes in the abandonment and conversion processes to the impact on internal systems and procedures as well as communications with licensees, adjusting to the new rules represents a significant challenge. But it’s a challenge that can be met and even bring improvements to TTO and research compliance operations if handled with a strong training component and a clear, detailed operational plan.

To help ensure a smooth transition and full compliance, Tech Transfer Central’s Distance Learning Division has secured an expert team from law firm Amster, Rothstein & Ebenstein LLP to lead a critical webinar, The 2018 Bayh Dole Revisions: Practical Compliance Guidance for Technology Transfer Offices, scheduled next Tuesday, July 17.

For complete details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

TOMORROW: The Founder’s Pie Calculator Workshop: How to Ensure Founders Get their Fair Share of Equity


By Jesse Schwartz
Published: June 27th, 2018

Splitting equity equally among start-up founders often leads to major problems that can be a death knell for new ventures. Why? Because some founders bring more to the table than others and should compensated as such. This is particularly true for university start-ups, which are more likely to have multiple founders — and where a faculty founder may have wildly different roles and responsibilities, as well as the IP contribution, when compared with a co-founding entrepreneur.

When it comes time to have the difficult conversation about equity shares, you’ll love having the tools and guidance provided in the webinar we’ve scheduled for TOMORROW, June 28: The Founder’s Pie Calculator Workshop: How to Ensure Founders Get their Fair Share of Equity. It’s not too late to register! Please join Frank Demmler, adjunct teaching professor of entrepreneurship at Carnegie Mellon University, for this 90-minute program that will teach you how to objectively, fairly divide start-up equity based on proven calculations. Each attendee will receive a copy of the calculator for their own use.

For complete details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

The 2018 Bayh Dole Revisions: Practical Compliance Guidance for Technology Transfer Offices


By Jesse Schwartz
Published: June 20th, 2018

Important revisions to the Bayh-Dole Act have now taken effect, and it’s critical for TTOs to ensure their compliance procedures are addressing the new rules. TTO leaders agree the changes will significantly increase the amount of time needed to assure full compliance.

From changes in the abandonment and conversion processes to the impact on internal systems and procedures as well as communications with licensees, adjusting to the new rules represents a significant challenge. But it’s a challenge that can be met and even bring improvements to TTO operations if handled with a strong training component and a clear, detailed operational plan.

To help TTOs ensure a smooth transition and full compliance, Tech Transfer Central’s Distance Learning Division has secured an expert team from law firm Amster, Rothstein & Ebenstein LLP to lead a critical webinar, The 2018 Bayh Dole Revisions: Practical Compliance Guidance for Technology Transfer Offices, scheduled for July 17.

For complete details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Proven Strategies for Reducing TTO Patent Expenses without Sacrificing Quality


By Jesse Schwartz
Published: June 20th, 2018

Your TTO’s patent budget is a major line item, and probably the single biggest area where your office can save significant dollars. The technologies you file on, the foreign filing decisions you make, the attorney fees you negotiate, and the firms you use are just some of the key factors that play into whether you spend wisely.

Technology Transfer Tactics’ Distance Learning Division has created a collection of distance learning programs that target key areas within your patent budget that should be redlined for cost and quality reviews. Each program is led by experts in the field and offer strategic takeaways you can implement immediately. The three-program collection includes:

  • How University TTOs Can Slash Patent Expenses While Improving Patent Quality
  • Best Practices for Cost-Effective Filing of PCT and EPO Patent Applications
  • Maximize Your TTO’s Patent Budget through Effective Use of Patent Counsel

For complete details on this cost-cutting collection and to order, CLICK HERE.

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

Drafting and Negotiating IP Rights in Sponsored Research Agreements


By Jesse Schwartz
Published: June 13th, 2018

A properly executed sponsored research agreement when partnering with industry is imperative to protect the university’s IP rights. Typically, an SRA will address ownership, licensing rights, confidentiality, publication rights, rights to future IP, and enforcement of all IP rights. Each term and condition of the agreement requires expert analysis and negotiation.

That’s why Technology Transfer Tactics’ Distance Learning Division is hosting an encore presentation of this critically important and highly rated one-hour program: Drafting and Negotiating IP Rights in Sponsored Research Agreements. The encore will be broadcast on June 21 at a special time, 11 a.m. eastern/4 p.m. London, to better accommodate our customers overseas who may have missed the original presentation.

Our experts — who have vast experience on both sides of the table — examine key considerations and outline critical provisions, while offering best practices for drafting and negotiating SRAs that protect your university’s interests without turning off industry sponsors. For complete details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News

The Founder’s Pie Calculator Workshop: How to Ensure Founders Get their Fair Share of Equity


By Jesse Schwartz
Published: June 6th, 2018

Splitting equity equally among start-up founders often leads to major problems that can be a death knell for new ventures. Why? Because some founders bring more to the table than others and should compensated as such. This is particularly true for university start-ups, which are more likely to have multiple founders — and where a faculty founder may have wildly different roles and responsibilities, as well as the IP contribution, when compared with a co-founding entrepreneur.

When it comes time to have the difficult conversation about equity shares, you’ll love having the tools and guidance provided in the webinar we’ve scheduled for June 28: The Founder’s Pie Calculator Workshop: How to Ensure Founders Get their Fair Share of Equity. Please join Frank Demmler, adjunct teaching professor of entrepreneurship at Carnegie Mellon University, for this 90-minute program that will teach you how to objectively, fairly divide equity in the company based on proven calculations. Each attendee will receive a copy of the calculator for their own use.

For complete details and to register, CLICK HERE.

ALSO COMING SOON:

→ No CommentsPosted under: Distance Learning, Tech Transfer e-News